ELOXX PHARMACEUTICALS, INC. (ELOX) Total liabilities 2012–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) total liabilities at each fiscal year-end, per SEC filings.
$17.2MFY2025 · since FY2012: $3.5M → $17.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.2M | -37.1% |
| FY2024 | $27.3M | +12.3% |
| FY2023 | $24.3M | — |
| FY2014 | $5.8M | +76.5% |
| FY2013 | $3.3M | -5.4% |
| FY2012 | $3.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice